No Barrier, a provider of AI-powered medical interpretation, announced the closing of a $2.7M seed round led by A Squared Ventures and Esplanade Ventures, with participation from Rock Health and Fusion. The funding will support expansion of real-time AI interpretation across clinical workflows nationwide.
No Barrier was founded to address inequities in healthcare communication. In the U.S., 25.7 million patients have limited English proficiency, and professional interpreters average only 75% accuracy. Delays, errors, and poor audio in traditional interpretation can prevent timely care, compromise patient safety, and disproportionately impact underserved communities.
“Our platform delivers instant, accurate, and private AI interpretation that integrates seamlessly into clinical workflows,” said the No Barrier team. “Language should never be the reason someone receives worse care.”
The platform supports interpretation across 40+ languages and dialects, covering every step of care from check-in and triage to diagnosis, treatment, and discharge. Health systems using No Barrier have reported immediate start of encounters, up to 70% cost reduction, higher patient satisfaction, and lower clinician burden. The solution is fully HIPAA and SOC 2 compliant.
No Barrier is operational at more than 100 sites in 12 states, including mental health, reproductive care, pediatrics, and infectious disease clinics. The company leverages AI–human hybrid interpretation to ensure accuracy, compliance, and consistent quality at scale.